Transfusion-related acute lung injury: A dangerous and underdiagnosed noncardiogenic pulmonary edema

Cardiology Journal

Volumn 20, Issue 4, 2013, Pages 337-344

  Jaworski, Krzysztof ^a   Maślanka, Krystyna ^b   Kosior, Dariusz A ^a,c  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c Radom University   (Poland)

Author keywords

Leukocyte antibodies; Pulmonary edema; Respiratory distress; Transfusion

Indexed keywords

DIURETIC AGENT; HLA ANTIBODY; OXYGEN; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ALGORITHM; ANTIGEN ANTIBODY COMPLEX; BLOOD COMPONENT; BLOOD TRANSFUSION; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL OXYGENATION; FATALITY; HUMAN; HYPERVOLEMIA; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; MEDICAL CARE; NONCARDIOGENIC LUNG EDEMA; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PLASMAPHERESIS; PROGNOSIS; RESPIRATORY DISTRESS; REVIEW; SEROLOGY; SYMPTOM; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT RESPONSE;

ACUTE LUNG INJURY; BLOOD TRANSFUSION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; PREDICTIVE VALUE OF TESTS; PULMONARY EDEMA; RISK FACTORS;

EID: 84885235426     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0091     Document Type: Review

References (50)

1. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. NY State J Med, 1951; 51: 2399-2402.
2. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis, 1983; 128: 185-189.
3. Kleinman S, Caulfield T, Chan P et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion, 2004; 44: 1774-1789.
4. Swanson K, Dwyre DM, Krochmal J, Raife TJ. Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations. Lung, 2006; 184: 177-185.
5. Müller MC, Juffermans NP. Transfusion-related acute lung injury: A preventable syndrome? Expert Rev Hematol, 2012; 5: 97-106.
6. Aravinthan A, Sen S, Marcus N. Transfusion-related acute lung injury: A rare and life-threatening complication of a common procedure. Clin Med, 2009; 9: 87-89.
7. Win N, Chapman CE, Bowles KM et al. How much residual plasma may cause TRALI? Transfus Med, 2008; 18: 276-280.
8. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: A review. Chest, 2004;126: 249-258.
9. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability//ReportaProblem/TransfusionDonationFatalities/default.htm.
10. Shaz BH. Giving TRALI the one-two punch. Blood, 2012; 119: 1620-1621.
11. Sanchez R, Bacchetti P, Toy P. Transfusion-related acute lung injury: a case-control pilot study of risk factors. Am J Clin Pathol, 2007;128: 128-134.
12. Toy P, Popovsky MA, Abraham E et al. Transfusion-related acute lung injury: definition and review. Crit. Care Med, 2005; 33: 721-726.
13. Shaz BH, Stowell SR, Hillyer CD. Transfusion-related acute lung injury: From bedside to bench and back. Blood, 2011; 117: 1463-1471.
14. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol, 2007, 136: 788-799.
15. Maślanka K,Zupańska B. Immunological and non-immunological factors implicated in TRALI-Polish experience. J Transf Med, 2012; 5: 88-90.
16. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev, 2009; 23: 266-283.
17. Silliman CC, Moore EE, Kelher MR et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion, 2011;51: 2549-2554.
18. Maślanka K, Smoleńska-Sym G, Michur H et al. Lysophosphatidylcholines: Bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp, 2012; 60: 55-60.
19. Wróbel A, Maślanka K, Uhrynowska M et al. Microparticles in blood components transfused to patients with dyspnea-associated non-hemolytic transfusion reactions. JTransf Med, 2012; 5: 65.
20. Óopacz P, Wróbel A, Sak-Budzisz J, Lachert E, Maślanka K, Brojer E. Ocena stẽZ̀enia IL-1beta, IL-6, IL-8, TNF-alpha i sCD40L w przechowywanych koncentratach erytrocytarnych i plytkowych. Acta Haematol Pol, 2011; 42: 85-93.
21. Virchis AE, Patel RK, Contreras M, Navarrete C, Kaczmarski RS, Jan-Mohamed R. Acute non-cardiogenic lung oedema after platelet transfusion. BMJ, 1997; 314: 880-882.
22. Eastlund DT, McGrath PC, Burkart P. Platelet transfusion reaction associated with interdonor HLA incompatibility. Vox Sang, 1988; 55: 157-160.
23. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (Trali) in a patient with a single lung transplant. Br J Haematol, 2000; 109: 674-676.
24. Maślanka K, Michur H, Zupańska B, Uhrynowska M, Nowak J. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang, 2007; 92: 247-249.
25. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood, 2005; 105: 2266-2273.
26. Covin RB, Ambruso DR, England KM et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: A case report and review of the literature. Transfus Med, 2004; 14: 375-383.
27. Zupanska B, Uhrynowska M, Michur H, Maślanka K, Zajko M. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang, 2007; 93: 70-77.
28. Vlaar AP, Hofstra JJ, Determann RM et al. The incidence, risk factors and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case control study. Blood, 2011; 117: 4219-4225.
29. Sachs UJ, Weissmann N, Wasel W et al. Supernatants from stored leukodepleted packed red blood cells do not regularly exhibit changes in their (lyso)phosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang, 2010; 99 (Suppl. s1): 456.
30. Triulzi DJ. Transfusion-related acute lung injury: An update. Hematol Am Soc Hematol Educ Program, 2006: 497-501.
31. Bierling P, Bux J, Curtis B et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang, 2009; 96: 266-269.
32. Reesink HW, Lee J, Keller A, Dennington P et al. Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang, 2012; 103: 231-259.
33. http://www.ihn-org.com/wp-content/uploads/2011/06/ISBT-definitions-for-non-infectious-transfusion-reactions.pdf.
34. Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med, 2006; 34: 109-113.
35. Danielson C, Benjamin RJ, Mangano MM, Mills CJ, Waxman DA. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration. Transfusion, 2008; 48: 2401-2408.
36. Roberts GH. Transfusion-related acute lung injury (TRALI). Clin Lab Sci, 2004; 17: 133-135.
37. Nouraei SM, Wallis JP, Bolton D, Hasan A. Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child. Br J Anaesth, 2003; 91: 292-294.
38. Wallis JP. Transfusion-related acute lung injury (TRALI)-under-diagnosed and under-reported. Br J Anaesth, 2003; 90: 573-576.
39. Lin Y, Kanani N, Naughton F, Pendergrast J, Karkouti K. Case report: Transfusion-related acute lung injury (TRALI) - A clear and present danger. Can J Anaesth, 2007; 54: 1011-1016.
40. Li G, Kojicic M, Reriani MK et al. Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest, 2010; 137: 783-789.
41. Kakaiya RM, Triulzi DJ, Wright DJ et al. Epidemiology Donor Study-II. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion, 2010; 50: 1328-1334.
42. Michala L, Madhavan B, Win N, De Lord C, Brown R. Transfusion-related acute lung injury (TRALI) in an obstetric patient. Int J Obstet Anesth, 2008; 17: 66-69.
43. Chapman CE, Stainsby D, Jones H et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion, 2009; 49: 440-452.
44. Lucas G, Win N, Calvert A et al. Reducing the incidence of TRALI in th UK: the results of screening for donor leucocyte antibodies and the development of national quidelines. Vox Sang, 2012; 102: 10-17.
45. Triulzi DJ, Kleinman S, Kakaiya RM et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion, 2009; 49: 1825-1835.
46. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA, 2002; 287: 1968-1971.
47. Lachert E, Antoniewicz-Papis J, Kubis J, Woź niak J, Ó towska M. PRT Mirasol System - validation experience in Poland. JTranf Med, 2012; 5: 91-93.
48. Krochmal JD, Dwyre DM, Swanson KM, Raife TJ, Schlueter AJ. Recurrent transfusion-related acute lung injury after a two-year interval. Transfus Med, 2007; 17: 192-196.
49. Win N, Montgomery J, Sage D, Street M, Duncan J, Lucas G. Recurrent transfusion-related acute lung injury. Transfusion, 2001; 41: 1421-1425.
50. Davis A, Mandal R, Johnson M, Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion, 2008; 48: 541-545.